Plasma and urinary trypsinogen activation peptide in healthy dogs, dogs with pancreatitis and dogs with other systemic diseases

Australian Veterinary Journal

Volumn 78, Issue 6, 2000, Pages 416-422

  Mansfield, C S ^a   Jones, B R ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Dog; Naturally occurring canine pancreatitis; Trypsinogen activation peptide

Indexed keywords

ANIMALIA; CANIS FAMILIARIS;

AMYLASE; CREATININE; OLIGOPEPTIDE; TRIACYLGLYCEROL LIPASE; TRYPSIN; TRYPSINOGEN ACTIVATION PEPTIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DIFFERENTIAL DIAGNOSIS; DOG; DOG DISEASE; KIDNEY DISEASE; PANCREATITIS; REFERENCE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THIN LAYER CHROMATOGRAPHY; URINE;

AMYLASES; ANIMALS; CHROMATOGRAPHY, THIN LAYER; CREATININE; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; KIDNEY DISEASES; LIPASE; OLIGOPEPTIDES; PANCREATITIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRYPSIN;

EID: 0034200924     PISSN: 00050423     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2000.tb11833.x     Document Type: Article

References (46)

1. Rinderknecht H. Activation of pancreatic zymogens: normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation. Dig Dis Sci 1986;31:314-321
2. Williams DA. The Pancreas. In: Guilford WG, Center SA, Strombeck DR, Williams DA, Meyer DJ, editors. Strombeck's Small Animal Gastroenterology. 3rd edn. Saunders, Philadelphia, 1996:381-410.
3. Greenbaum LM, Hirshkowitz A. Endogenous cathepsin activation of trypsinogen in extracts of dog pancreas. Proc Soc Exp Biol Med 1961;107:74-76.
4. Figarella C, Miszczuk-Jamska B, Barret AJ. Possible lysosomal activation of pancreatic zymogens: activation of both human trypsinogens by cathepsin B and spontaneous acid activation of human trypsinogen. J. Biol Chem 1988;369:293-8.
5. Steer ML, Meldolesi J, Figarella C. The role of lysosomes. Dig Dis Sci 1984;29:934-8.
6. Willemer S, Bialek R, Adler G. Localization of lysosomal and digestive enzymes in cytoplasmic vacuoles in caerulein-pancreatitis. Histochemistry 1990;94:161-170.
7. Simpson KW. Current concepts of the pathogenesis and pathophysiology of acute pancreatitis in the dog and cat. Compend Conf Educ 1993;15:247-251.
8. Yamaguchi H, Kimura T, Mimura K, Nawata H. Activation of proteases in cerulein-induced pancreatitis. Pancreas 1989;4:565-571.
9. Saluja AK, Donovan EA, Yamanaka K et al. Caerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 1997;113:304-310.
10. Luthen R, Owen RL, Sarbia M, Grendell JH, Niederau C. Premature trypsinogen activation during cerulein pancreatitis in rats occurs inside pancreatic acinar cells. Pancreas 1998;17:38-43.
11. Fernandez-Del-Castillo C, Schmidt J, Warshaw AL, Rattner DW. Interstitial protease activation is the central event in progression to necrotizing pancreatitis. Surgery 1994;116:497-504.
12. Klonowski-Stumpe H, Luthen R, Han B et al. Inhibition of cathepsin B does not affect the intracellular activation of trypsinogen by cerulein hyperstimulation in isolated rat pancreatic acinar cells. Pancreas 1998;16:96-101.
13. Heath DI, Cruickshank A, Gudgeon A.M et al. The relationship between pancreatic enzyme release and activation and the acute-phase protein response in patients with acute pancreatitis. Pancreas 1995;10:347-353.
14. Nakae Y, Naruse S, Kitagawa M et al. Activation of trypsinogen in experimental models of acute pancreatitis in rats. Pancreas 1995;10:306-313.
15. Halangk W, Sturzebecher J, Matthias R, Schulz H, Lippert H. Trypsinogen activation in rat pancreatic acinar cells hyperstimulated by caerulin. Biochem Biophys Acta 1997;1362:243-251.
16. 1 -protease inhibitor complexes in serum and clinical course of acute pancreatitis. Scand J Gastroenterol 1984;19:1119-1122.
17. Lasson A, Ohlsson K. Acute pancreatitis. The correlation between clinical course, protease inhibitors, and complement and kinin activation. Scand J Gastroenterol 1984;19:707-710.
18. Hurley PR, Cook A, Jehanli A, Austen BM, Hermon-Taylor J. Development of radioimmunoassays for free tetra-l-aspartyl-l-lysine trypsinogen activation peptides (TAP). J Immunol Methods 1988;111:195-203.
19. Geokas MC, Largman C, Durie PR et al. Immunoreactive forms of cationic trypsin in plasma and ascitic fluid of dogs in experimental pancreatitis. Am J Pathol 1981;105:31-39.
20. Heath DI, Wilson C, Gudgeon AM et al. Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients and their relation to the presence of histologically confirmed pancreatic necrosis. Gut 1994;35:1311-1315.
21. Gudgeon AM, Heath DI, Hurley P et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990;335:4-8.
22. Foitzik T, Hotz HG, Schmidt J et al. Effect of microcirculatory perfusion on distribution of trypsinogen activation peptides in acute experimental pancreatitis. Dig Dis Sci 1995;40:2184-2188.
23. 1-PI) and plasma trypsinogen activation peptides (TAP) in canine experimental pancreatitis. In: BSAVA Congress Paper Synopses, British Small Animal Veterinary Association, April 1998.
24. Beechey-Newman N, Simpson KW, Rae D, Sumar N, Hermon-Taylor J. Specific diagnosis of canine acute pancreatitis by an ELISA for trypsinogen activation peptide. J Vet Intern Med 1994;8:151.
25. Simpson KW, Beechey-Newman N, Lamb C et al. Cholecystokinin-8 induces edematous pancreatitis in dogs associated with short burst of trypsinogen activation. Dig Dis Sci 1995;40:2152-2161.
26. Williams DA , Batt RM. Sensitivity and specificity of radioimmunoassay of serum trypsin-like immunoreactivity for the diagnosis of canine exocrine pancreatic insufficiency. J Am Vet Med Assoc 1988;192:195-201.
27. Biotrin, Dublin, Ireland. Enzyme immunoassay for the quantitation of trypsinogen activation peptide (TAP). Instructions for use 1999.
28. Ruaux CG, Atwell R. General practice attitudes to the treatment of spontaneous canine acute pancreatitis. Aust Vet Pract 1998;28:67-74.
29. Simpson KW, Lamb CR. Acute pancreatitis in the dog. In Pract 1995;17:328-337.
30. Hess RS, Kass PH, Shofer FS, Van Winkle TJ, Washabau RJ. Evaluation of risk factors for fatal acute pancreatitis in dogs. J Am Vet Med Assoc 1999;214:46-51.
31. Ruaux CG, Atwell R. A severity score for spontaneous canine acute pancreatitis. Aust Vet J 1998;76:804-808.
32. Cook AK, Breitschwerdt EB, Levine JF, Bunch SE, Linn LO. Risk factors associated with acute pancreatitis in dogs: 101 cases (1985-1990). J Am Vet Med Assoc 1993;203:673-679.
33. Whitney MS The laboratory assessment of canine and feline pancreatitis. Vet Med 1993;85:1045-1052.
34. Willard MD, Wolf AM, Green R. Duodenal foreign body mimicking acute pancreatitis. J Am Anim Hosp Assoc 1993;29:351-354.
35. Walter GL, McGraw P, Tvedten HW Serum lipase determination in the dog: a comparison of a titrimetric method with an automated kinetic method. Vet Clin Pathol 1992;21:23-27.
36. Simpson KW, Batt RM, McLean L, Morton DB. Circulating concentrations of trypsin-like immunoreactivity and activities of lipase and amylase after pancreatic duct ligation in dogs. Am J Vet Res 1989;50:629-632.
37. Akuzawa M, Morizono M, Nagata K. et al. Changes of serum amylase, its isoenzyme fractions and amylase-creatinine clearance ratio in dogs with experimentally induced acute pancreatitis. J Vet Med Sci 1993;56:269-273.
38. Jacobs R., Murtaugh RJ, DeHoff WD. Review of the clinicopathological findings of acute pancreatitis in the dog: use of an experimental model J Am Anim Hosp Assoc 1985;21:795-800.
39. Williams DA. Diagnosis and management of pancreatitis. J Small Animal Pract 1994;35:445-454.
40. Rallis TS, Koutinas AF, Kritsepi MG, Moraitou KT. Serum lipase activity in young dogs with acute enteritis or gastroenteritis. Vet Clin Pathol 1996;25:65-68.
41. Hess RS, Saunders HM, Van Winkle TJ, Shofer FS, Washabau RJ. Clinical, clinicopathologic, radiographic, and ultrasonographic abnormalities in dogs with fatal acute pancreatitis: 70 cases (1986-1995). J Am Vet Med Assoc 1998;213:665-670.
42. Stewart AF. Pancreatitis in dogs and cats: cause, pathogenesis, diagnosis, and treatment. Compend Cont Educ 1994;16:1423-1430
43. Batt RM. Exocrine pancreatic insufficiency. Vet Clin North Am 1993;23:595- 608
44. Banks PA, Carr-Locke DL, Slivka A. et al. Urinary trypsinogen activation peptides (TAP) are not increased in mild ercp-induced pancreatitis. Pancreas 1996;12:294-297
45. Schmidt J, Fernandez Del-Castillo C, Rattner DW et al. Trypsinogen-activation peptides in experimental rat pancreatitis: prognostic implications and histopathologic correlates. Gastroenterology 1992;103:1009-1016.
46. Schmidt J, Ryschich E, Sinn HP et al. Trypsinogen activation peptides (TAP) in peritoneal fluid as predictors of late histopathologic in ury in necrotizing pancreatitis of the rat. Dig Dis Sci 1999;44:823-829.